Phase II Study of HMPL-004 in Subjects With Crohn's Disease

NCT00655733 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: HMPL-004
DRUG: Placebo

Sponsor

Hutchison Medipharma Limited